Commentary · 21 Feb 2026
Conference abstractPublished 3 Oct 2016
BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells
Chinese Academy of Medical Sciences & Peking Union Medical College, China
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
B-cell CLL/lymphoma 6 (BCL6), a transcriptional repressor, is involved in the development and progression of breast cancers with uncertain mechanism. It was found that the expression of BCL6 positively associates with poor survival of breast cancer patients. The purpose of this study is to investigate the potential effect and mechanism of BCL6 in the regulation of epithelialmesenchymal transition (EMT), a critical cellular process for controlling the development and progression of breast cancers. We found that BCL6 promoted invasion, migration and growth by stimulating EMT in breast cancer cells. BCL6 induced EMT by enhancing the expression of transcriptional repressor ZEB1 which bound to the E-cadherin promoter and repressing the E-cadherin transcription. Deletion of ZEB1 protected against the pro-EMT roles of BCL6 by restoring the expression of E-cadherin in these cells. Moreover, inhibition of BCL6 with BCL6 inhibitor 79-6 suppressed these functions of BCL6 in breast cancer cells. These findings indicate that BCL6 promotes EMT via enhancing the ZEB1-mediated transcriptional repression of E-cadherin in breast cancer cells. Moreover, we recently find that BCL6 is involved in the dormancy-reactivation pathway from the published clinical breast cancer database, and BCL6 initiates and maintains cancer stem cell activity. Targeting BCL6 has therapeutic potential against the development and progression of breast cancer.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Cui Bing”
- BylineArticles whose byline prints “Hu Zhuowei”
- BylineArticles whose byline prints “Yu Jinmei”
